- Home
- TORO vs PYPD Comparison
TORO vs PYPD Comparison
Compare TORO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TORO
- PYPD
- Stock Information
- Founded
- TORO 2022
- PYPD 2008
- Country
- TORO Cyprus
- PYPD Israel
- Employees
- TORO N/A
- PYPD N/A
- Industry
- TORO Marine Transportation
- PYPD Medical/Dental Instruments
- Sector
- TORO Consumer Discretionary
- PYPD Health Care
- Exchange
- TORO Nasdaq
- PYPD Nasdaq
- Market Cap
- TORO 36.7M
- PYPD 36.0M
- IPO Year
- TORO N/A
- PYPD 2020
- Fundamental
- Price
- TORO $2.93
- PYPD $3.40
- Analyst Decision
- TORO
- PYPD Strong Buy
- Analyst Count
- TORO 0
- PYPD 5
- Target Price
- TORO N/A
- PYPD $11.40
- AVG Volume (30 Days)
- TORO 752.9K
- PYPD 215.1K
- Earning Date
- TORO 08-11-2025
- PYPD 08-13-2025
- Dividend Yield
- TORO N/A
- PYPD N/A
- EPS Growth
- TORO N/A
- PYPD N/A
- EPS
- TORO 1.09
- PYPD N/A
- Revenue
- TORO $22,394,283.00
- PYPD N/A
- Revenue This Year
- TORO N/A
- PYPD N/A
- Revenue Next Year
- TORO N/A
- PYPD N/A
- P/E Ratio
- TORO $2.78
- PYPD N/A
- Revenue Growth
- TORO 0.40
- PYPD N/A
- 52 Week Low
- TORO $1.70
- PYPD $2.30
- 52 Week High
- TORO $4.05
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- TORO 75.13
- PYPD 51.00
- Support Level
- TORO $2.12
- PYPD $3.34
- Resistance Level
- TORO $2.29
- PYPD $3.53
- Average True Range (ATR)
- TORO 0.20
- PYPD 0.15
- MACD
- TORO 0.05
- PYPD -0.04
- Stochastic Oscillator
- TORO 71.13
- PYPD 14.68
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.